Ross JS - Search Results

1

Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.

Kren L, Goncharuk VN, Krenová Z, Stratil D, Hermanová M, Skricková J, Sheehan CE, Ross JS. Kren L, et al. Among authors: ross js. Cesk Patol. 2006 Jan;42(1):16-9. Cesk Patol. 2006. PMID: 16506596

2

E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder.

Ross JS, del Rosario AD, Figge HL, Sheehan C, Fisher HA, Bui HX. Ross JS, et al. Hum Pathol. 1995 Sep;26(9):940-4. doi: 10.1016/0046-8177(95)90081-0. Hum Pathol. 1995. PMID: 7672793

3

E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology.

Ross JS, Cheung C, Sheehan C, del Rosario AD, Bui HX, Fisher HA. Ross JS, et al. Diagn Cytopathol. 1996 Jun;14(4):310-5. doi: 10.1002/(SICI)1097-0339(199605)14:4<310::AID-DC6>3.0.CO;2-J. Diagn Cytopathol. 1996. PMID: 8725130

4

MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.

Ambros RA, Sheehan CE, Kallakury BV, Ross JS, Malfetano J, Paunovich E, Figge J. Ambros RA, et al. Among authors: ross js. Mod Pathol. 1996 Dec;9(12):1165-9. Mod Pathol. 1996. PMID: 8972476

5

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma.

Ross JS, Sheehan CE, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman RP Jr, Fisher HA, Rifkin MD, Muraca PJ. Ross JS, et al. Cancer. 1997 Jun 1;79(11):2162-70. doi: 10.1002/(sici)1097-0142(19970601)79:11<2162::aid-cncr14>3.0.co;2-u. Cancer. 1997. PMID: 9179063

6

Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.

Tran TA, Kallakury BV, Sheehan CE, Ross JS. Tran TA, et al. Among authors: ross js. Hum Pathol. 1997 Jul;28(7):809-14. doi: 10.1016/s0046-8177(97)90154-4. Hum Pathol. 1997. PMID: 9224749

7

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization.

Ross JS, Sheehan C, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman R, Fisher HA, Muraca PJ. Ross JS, et al. Hum Pathol. 1997 Jul;28(7):827-33. doi: 10.1016/s0046-8177(97)90157-x. Hum Pathol. 1997. PMID: 9224752

8

The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.

Kallakury BV, Sheehan CE, Ambros RA, Fisher HA, Kaufman RP Jr, Ross JS. Kallakury BV, et al. Among authors: ross js. Cancer. 1997 Aug 15;80(4):753-63. doi: 10.1002/(sici)1097-0142(19970815)80:4<753::aid-cncr15>3.0.co;2-s. Cancer. 1997. PMID: 9264360

9

Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas.

Kallakury BV, Sheehan CE, Ambros RA, Fisher HA, Kaufman RP Jr, Muraca PJ, Ross JS. Kallakury BV, et al. Among authors: ross js. J Clin Oncol. 1998 Apr;16(4):1302-9. doi: 10.1200/JCO.1998.16.4.1302. J Clin Oncol. 1998. PMID: 9552030

10

Cell proliferation rate by MIB-1 immunohistochemistry predicts postradiation recurrence in prostatic adenocarcinomas.

Scalzo DA, Kallakury BV, Gaddipati RV, Sheehan CE, Keys HM, Savage D, Ross JS. Scalzo DA, et al. Among authors: ross js. Am J Clin Pathol. 1998 Feb;109(2):163-8. doi: 10.1093/ajcp/109.2.163. Am J Clin Pathol. 1998. PMID: 9583887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,777 results

Search Page

Filters